X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (59425) 59425
Newspaper Article (466) 466
Book Chapter (303) 303
Newsletter (293) 293
Book / eBook (130) 130
Magazine Article (96) 96
Web Resource (52) 52
Dissertation (47) 47
Conference Proceeding (35) 35
Publication (17) 17
Book Review (4) 4
Streaming Video (4) 4
Government Document (2) 2
Paper (2) 2
Journal / eJournal (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (52904) 52904
science & technology (46920) 46920
life sciences & biomedicine (44032) 44032
colorectal cancer (36301) 36301
female (29577) 29577
male (28743) 28743
oncology (26671) 26671
middle aged (24086) 24086
aged (22635) 22635
colorectal neoplasms - pathology (19676) 19676
cancer (17193) 17193
adult (15617) 15617
colorectal neoplasms - drug therapy (14078) 14078
surgery (12484) 12484
metastasis (10049) 10049
aged, 80 and over (10021) 10021
prognosis (9945) 9945
colorectal neoplasms - genetics (8884) 8884
tumors (8743) 8743
chemotherapy (8728) 8728
treatment outcome (8578) 8578
animals (8157) 8157
research (8088) 8088
care and treatment (7983) 7983
medicine & public health (7875) 7875
analysis (7129) 7129
gastroenterology & hepatology (6722) 6722
neoplasm staging (6679) 6679
health aspects (6267) 6267
liver neoplasms - secondary (6244) 6244
retrospective studies (6181) 6181
colorectal carcinoma (6144) 6144
cell line, tumor (6123) 6123
antineoplastic combined chemotherapy protocols - therapeutic use (6022) 6022
colorectal neoplasms - mortality (5912) 5912
colorectal neoplasms - metabolism (5834) 5834
risk factors (5691) 5691
colorectal neoplasms - surgery (5511) 5511
cancer therapies (5501) 5501
colorectal neoplasms - therapy (5338) 5338
mice (5027) 5027
apoptosis (4738) 4738
patients (4730) 4730
gene expression (4651) 4651
colon cancer (4592) 4592
genetic aspects (4573) 4573
gastroenterology (4520) 4520
mutation (4478) 4478
survival rate (4411) 4411
proteins (4296) 4296
medical prognosis (4287) 4287
abridged index medicus (4138) 4138
antineoplastic agents - therapeutic use (4099) 4099
research article (4057) 4057
studies (4024) 4024
survival analysis (3995) 3995
fluorouracil - administration & dosage (3954) 3954
follow-up studies (3868) 3868
colorectal neoplasms - diagnosis (3837) 3837
development and progression (3813) 3813
medicine (3746) 3746
neoplasm metastasis (3711) 3711
disease-free survival (3677) 3677
immunohistochemistry (3386) 3386
gene expression regulation, neoplastic (3183) 3183
prospective studies (3148) 3148
metastases (3135) 3135
oncology, experimental (3109) 3109
breast cancer (3067) 3067
medical research (3042) 3042
cell biology (3013) 3013
surgical oncology (3008) 3008
combined modality therapy (2982) 2982
colorectal surgery (2961) 2961
diagnosis (2956) 2956
neoplasms. tumors. oncology. including cancer and carcinogens (2927) 2927
kinases (2892) 2892
science & technology - other topics (2891) 2891
digestive system diseases (2885) 2885
survival (2863) 2863
time factors (2855) 2855
pathology (2794) 2794
colon (2749) 2749
multidisciplinary sciences (2744) 2744
mortality (2692) 2692
pharmacology & pharmacy (2678) 2678
liver neoplasms - surgery (2648) 2648
cell proliferation (2607) 2607
biomarkers (2596) 2596
internal medicine (2573) 2573
camptothecin - analogs & derivatives (2570) 2570
liver neoplasms - drug therapy (2534) 2534
adenocarcinoma - pathology (2528) 2528
colonic neoplasms - pathology (2517) 2517
signal transduction (2474) 2474
colorectal neoplasms (2455) 2455
rectal neoplasms - pathology (2442) 2442
cancer patients (2418) 2418
hepatology (2408) 2408
chemotherapy, adjuvant (2395) 2395
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (49) 49
Gerstein Science - Stacks (30) 30
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (15) 15
Scarborough Hospital - Online (2) 2
Baycrest Hospital - Wellness Library (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Credit Valley Hospital - Online (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (58665) 58665
Japanese (998) 998
German (696) 696
French (505) 505
Chinese (357) 357
Italian (191) 191
Spanish (189) 189
Russian (149) 149
Portuguese (113) 113
Hungarian (71) 71
Czech (70) 70
Danish (40) 40
Korean (40) 40
Polish (37) 37
Dutch (31) 31
Norwegian (30) 30
Swedish (18) 18
Romanian (17) 17
Ukrainian (13) 13
Bulgarian (11) 11
Croatian (10) 10
Serbian (10) 10
Hebrew (8) 8
Finnish (7) 7
Slovak (7) 7
Persian (4) 4
Arabic (3) 3
Lithuanian (3) 3
Turkish (3) 3
Icelandic (2) 2
Slovenian (2) 2
Bosnian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International journal of radiation oncology, biology, physics, ISSN 0360-3016, 07/2012, Volume 83, Issue 3, pp. 878 - 886
Purpose To analyze the long-term survival and tumor control outcomes after stereotactic body radiotherapy (SBRT... 
Radiology | Hematology, Oncology and Palliative Medicine | Stereotactic body radiotherapy | Breast cancer | Oligometastases | Survival | Metastases | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Bone Neoplasms - mortality | Sarcoma - secondary | Prospective Studies | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Carcinoma, Squamous Cell - surgery | Liver Neoplasms - mortality | Radiosurgery - adverse effects | Brain Neoplasms - surgery | Esophageal Neoplasms - pathology | Brain Neoplasms - secondary | Carcinoma, Squamous Cell - mortality | Lung Neoplasms - secondary | Sarcoma - mortality | Aged, 80 and over | Adult | Female | Brain Neoplasms - mortality | Liver Neoplasms - secondary | Radiosurgery - methods | Colorectal Neoplasms - mortality | Neoplasm Metastasis - radiotherapy | Liver Neoplasms - surgery | Lymphatic Metastasis | Bone Neoplasms - surgery | Adenocarcinoma - secondary | Head and Neck Neoplasms - pathology | Breast Neoplasms - pathology | Sarcoma - surgery | Breast Neoplasms - mortality | Carcinoma, Squamous Cell - secondary | Lung Neoplasms - surgery | Aged | Head and Neck Neoplasms - mortality | Colorectal Neoplasms - pathology | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Radiotherapy | Nuclear radiation | Analysis | Radiation | Index Medicus | MULTIVARIATE ANALYSIS | PATIENTS | MAMMARY GLANDS | NEOPLASMS | METASTASES | RADIOLOGY AND NUCLEAR MEDICINE | DEATH | REGRESSION ANALYSIS | RADIOTHERAPY | HAZARDS | SKELETON
Journal Article
Current drug targets, ISSN 1389-4501, 11/2015, Volume 16, Issue 12, pp. 1381 - 1403
MicroRNAs (miRNAs) are small single stranded non coding RNA molecules (similar to 22 nucleotides) which impede protein production by directly interacting with... 
Epithelial to mesenchymal transition | Biomarker | Tumor microenvironment | Tumor suppressor | MicroRNAs | MiR-200c | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | MicroRNAs - therapeutic use | Neoplasms - metabolism | Lung Neoplasms - drug therapy | Prostatic Neoplasms - metabolism | Pancreatic Neoplasms - metabolism | Pancreatic Neoplasms - diagnosis | Humans | Lung Neoplasms - metabolism | Endometrial Neoplasms - metabolism | Stomach Neoplasms - metabolism | Male | MicroRNAs - metabolism | Antineoplastic Agents - therapeutic use | Neoplasms - diagnosis | Prostatic Neoplasms - diagnosis | Colorectal Neoplasms - diagnosis | Breast Neoplasms - metabolism | Pancreatic Neoplasms - drug therapy | Biomarkers, Tumor - therapeutic use | Colorectal Neoplasms - drug therapy | Biomarkers, Tumor - metabolism | Female | Ovarian Neoplasms - metabolism | Ovarian Neoplasms - drug therapy | Colorectal Neoplasms - metabolism | Prostatic Neoplasms - drug therapy | Stomach Neoplasms - diagnosis | Ovarian Neoplasms - diagnosis | Biomarkers, Tumor - physiology | Stomach Neoplasms - drug therapy | Endometrial Neoplasms - diagnosis | Breast Neoplasms - drug therapy | Neoplasms - drug therapy | Animals | Endometrial Neoplasms - drug therapy | Breast Neoplasms - diagnosis | MicroRNAs - physiology | Lung Neoplasms - diagnosis
Journal Article
Clinical colorectal cancer, ISSN 1533-0028, 2001
Journal
World journal of surgery, ISSN 0364-2313, 2/2012, Volume 36, Issue 2, pp. 386 - 391
Journal Article
EMBO molecular medicine, ISSN 1757-4684, 09/2014, Volume 6, Issue 10, pp. 1279 - 1293
Epithelial‐mesenchymal transition (EMT) is a reversible and dynamic process hypothesized to be co‐opted by carcinoma during invasion and metastasis. Yet, there... 
drug response | microarray | gene expression signature | epithelial‐mesenchymal transition | prognosis | Drug response | Epithelial-mesenchymal transition | Prognosis | Microarray | Gene expression signature | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Lung Neoplasms - drug therapy | Oligonucleotide Array Sequence Analysis | Colorectal Neoplasms - genetics | Humans | Epithelial-Mesenchymal Transition - drug effects | Antineoplastic Agents - therapeutic use | Epithelial-Mesenchymal Transition - genetics | Ovarian Neoplasms - genetics | Urinary Bladder Neoplasms - genetics | Neoplasms - genetics | Colorectal Neoplasms - drug therapy | Female | Gene Expression Regulation, Neoplastic - drug effects | Ovarian Neoplasms - drug therapy | Lung Neoplasms - genetics | Stomach Neoplasms - genetics | Treatment Outcome | Transcriptome - drug effects | Transcriptome - genetics | Stomach Neoplasms - drug therapy | Urinary Bladder Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Neoplasms - drug therapy | Disease-Free Survival | Breast Neoplasms - genetics | Cell Line, Tumor | Cancer patients | Chemotherapy | Patient outcomes | Stem cells | Development and progression | Drug therapy | Gene expression | Ovarian cancer | Cancer | Mesenchyme | Colorectal carcinoma | Genomes | Breast cancer | Metastasis | Kinases | Cancer therapies | Metastases | Breast carcinoma | Genotype & phenotype | Paclitaxel | Breast | Software | Tumors | Index Medicus | epithelial-mesenchymal transition
Journal Article
Clinical Lung Cancer, ISSN 1525-7304, 2017, Volume 18, Issue 5, pp. 543 - 550.e3
Background –Patients with prior malignancies may be at increased risk for non-small cell lung cancer (NSCLC). However, the extent of risk is unknown for many... 
Hematology, Oncology and Palliative Medicine | Pulmonary/Respiratory | NSCLC | Survivor | Radiation | Screening criteria | Smoking | Life Sciences & Biomedicine | Oncology | Science & Technology | Melanoma - epidemiology | Smoking - adverse effects | Lung Neoplasms - ethnology | United States - epidemiology | Prostatic Neoplasms - radiotherapy | Kidney Neoplasms - epidemiology | Pancreatic Neoplasms - epidemiology | Neoplasms, Second Primary - ethnology | Humans | Middle Aged | Thyroid Neoplasms - epidemiology | Uterine Neoplasms - epidemiology | Colorectal Neoplasms - radiotherapy | Male | Hematologic Neoplasms - epidemiology | Incidence | Hematologic Neoplasms - radiotherapy | Head and Neck Neoplasms - epidemiology | Female | Uterine Neoplasms - radiotherapy | Urinary Bladder Neoplasms - epidemiology | Adenocarcinoma - radiotherapy | Breast Neoplasms - epidemiology | Colorectal Neoplasms - epidemiology | SEER Program | Risk Factors | Melanoma - radiotherapy | Carcinoma, Non-Small-Cell Lung - epidemiology | Pancreatic Neoplasms - radiotherapy | Carcinoma, Non-Small-Cell Lung - ethnology | Thyroid Neoplasms - radiotherapy | Kidney Neoplasms - radiotherapy | Neoplasms, Second Primary - epidemiology | Prostatic Neoplasms - epidemiology | Head and Neck Neoplasms - radiotherapy | Breast Neoplasms - radiotherapy | Urinary Bladder Neoplasms - radiotherapy | Lung Neoplasms - epidemiology | Smoking - epidemiology | Sex Factors | Aged | Adenocarcinoma - epidemiology | Index Medicus | screening criteria | radiation | smoking | survivor
Journal Article
The New England journal of medicine, ISSN 1533-4406, 10/2014, Volume 371, Issue 17, pp. 1609 - 1618
In patients with metastatic colon cancer, fluorouracil, oxaliplatin, and irinotecan plus bevacizumab, as compared with fluorouracil and irinotecan plus... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Bevacizumab | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Adult | Female | Leucovorin - therapeutic use | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Camptothecin - therapeutic use | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Treatment outcome | Care and treatment | Analysis | Colorectal cancer | Dosage and administration | Leucovorin | Fluorouracil | Colorectal carcinoma | Diarrhea | Metastasis | Survival | Patients | Clinical outcomes | Metastases | Irinotecan | Stomatitis | Chemotherapy | Neurotoxicity | Oxaliplatin | Monoclonal antibodies | Vascular endothelial growth factor | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
PloS one, ISSN 1932-6203, 06/2017, Volume 12, Issue 6, pp. e0179501 - e0179501
Innovative therapies for solid tumors are urgently needed. Recently, therapies that harness the host immune system to fight cancer cells have successfully treated a subset of patients with solid tumors... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Colonic Neoplasms - genetics | DNA Methylation - immunology | DNA, Neoplasm - metabolism | Humans | Antigens, Neoplasm - biosynthesis | Ovarian Neoplasms - pathology | Male | Colonic Neoplasms - metabolism | Testicular Neoplasms - pathology | Ovarian Neoplasms - genetics | Colonic Neoplasms - immunology | Female | Ovarian Neoplasms - metabolism | Caco-2 Cells | Antigens, Neoplasm - genetics | Testicular Neoplasms - genetics | Antigens, Neoplasm - immunology | Testicular Neoplasms - metabolism | Antigen Presentation - genetics | DNA Methylation - genetics | Testicular Neoplasms - immunology | Animals | Colonic Neoplasms - pathology | DNA, Neoplasm - immunology | Mice | DNA, Neoplasm - genetics | Ovarian Neoplasms - immunology | Colon cancer | Tumor antigens | Physiological aspects | Development and progression | Genetic aspects | Research | Methylation | Ovarian cancer | Therapy | Biotechnology | Animal models | Ovarian carcinoma | Medical innovations | CD58 antigen | Antigen processing | Genomes | Tissues | Cancer therapies | Immunotherapy | Surgery | Cell cycle | DNA methylation | Inhibition | Colon | Drug dosages | Deoxyribonucleic acid--DNA | Immune system | Antigen presentation | Antigens | Tumor cells | Melanoma | Tumor cell lines | Gene expression | Ribonucleic acid--RNA | Patients | Medicine | Inhibitors | Epigenetics | Solid tumors | Tumors | Cancer | Index Medicus | RNA | Deoxyribonucleic acid | Ribonucleic acid | DNA
Journal Article